Solid lipid nanoparticles carrying lipophilic derivatives of doxorubicin: preparation, characterization, and in vitro cytotoxicity studies

References

• Barraud L, Merle P, Soma E, Lefrancois L, Guerret S, Chevallier M, Dubernet C, Couvreur P, Trepo C, Vitvitski L. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol, 2005;42:736–43.
   PubMed Web of Science ®Google Scholar
• Battaglia L, Gallarate M, Cavalli R, Trotta M. Solid lipid nanoparticles produced through a coacervation method. J Microencapsulation, 2010;27:78–85.
   PubMed Web of Science ®Google Scholar
• Battaglia L, Gallarate M, Peira E, Chirio D, Muntoni E, Biasibetti E, Capucchio MT, Valazza A, Panciani PP, Lanotte M, et al. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: Preliminary in vitro studies. J Pharm Sci, 2014;103:2157–65.
   PubMed Web of Science ®Google Scholar
• Chhikara BS, Jean NS, Mandal D, Kumar A, Parang K. Fatty acyl amide derivatives of doxorubicin: Synthesis and in vitro anticancer activities. Eur J Med Chem, 2011;46:2037–42.
   PubMed Web of Science ®Google Scholar
• Chirio D, Gallarate M, Peira E, Battaglia L, Serpe L, Trotta M. Formulation of curcumin-loaded solid lipid nanoparticles produced by fatty acids coacervation technique. J Microencapsul, 2011;28(6):537–48.
   PubMed Web of Science ®Google Scholar
• Chirio D, Gallarate M, Peira E, Battaglia L, Muntoni E, Riganti C, Biasibetti E, Capucchio MT, Valazza A, Panciani P, et al. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment. Eur J Pharm Biopharm, 2014;88(3):746–58.
   PubMed Web of Science ®Google Scholar
• de Graaf M, Nevalainen TJ, Scheeren HW, Pinedo HM, Haisma HJ, Boven E. A methylester of the glucuronide prodrug DOX-GA3 for improvement of tumor-selective chemotherapy. Biochem Pharmacol, 2004;68(11):2273–8.
   PubMed Web of Science ®Google Scholar
• Devalapally H, Duan Z, Seiden MV, Amiji MM. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int J Cancer, 2007;121:1830–8.
   PubMed Web of Science ®Google Scholar
• Dikmen G, Güney G, Genc L. Characterization of solid lipid nanoparticles containing caffeic acid and determination of its effects on MCF-7 cells. Recent Pat Anticancer Drug Discov, 2015;10(2):224–32.
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Souto EB, Silva AM. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – A systematic review of in vitro data. Eur J Pharm Biopharm, 2014;87:1–18.
   PubMed Web of Science ®Google Scholar
• Duggan ST, Keating GM. Pegylated liposomal doxorubicin: A review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Drugs, 2011;71:2531–58.
   PubMed Web of Science ®Google Scholar
• Gallarate M, Serpe L, Foglietta F, Zara GP, Giordano S, Peira E, Chirio D, Battaglia L. Solid lipid nanoparticles loaded with fluorescent-labelled Cyclosporine A: Anti-inflammatory activity in vitro. Protein Pept Lett, 2014;21(11):1157–62.
   PubMed Web of Science ®Google Scholar
• Ganta S, Amiji M. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm, 2009;6:928–39.
   PubMed Web of Science ®Google Scholar
• Gasco MR, Morel S, Ugazio E, Cavalli R. Thymopentin in solid lipid nanoparticles. Int J Pharm, 1996;132:259–61.
   Web of Science ®Google Scholar
• Giovinazzo H, Kumar P, Sheikh A, Brooks KM, Ivanovic M, Walsh M, Caron WP, Kowalsky RJ, Song G, Whitlow A, et al. Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer. Cancer Chemother Pharmacol, 2016;77:565–73.
   PubMed Web of Science ®Google Scholar
• Güney G, Kutlu HM, Genç L. Preparation and characterization of ascorbic acid loaded solid lipid nanoparticles and investigation of their apoptotic effects. Colloids Surf B Biointerfaces, 2014;121(1):270–80.
   PubMed Web of Science ®Google Scholar
• Ibsen S, Zahavy E, Wrasdilo W, Berns M, Chan M, Esener S. A novel Doxorubicin prodrug with controllable photolysis activation for cancer chemotherapy. Pharm Res, 2010;27(9):1848–60.
   PubMed Web of Science ®Google Scholar
• Iyer AK, Singh A, Ganta SB, Amiji MM. Role of integrated cancer nanomedicine in overcoming drug resistance. Adv Drug Deliv Rev, 2013;65:1784–802.
   PubMed Web of Science ®Google Scholar
• Kushwaha AK, Vuddanda PR, Priyanka K, Singh SK, Singh S. 2013. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability. BioMed Res Int, 2013;2013:584549.
   PubMed Web of Science ®Google Scholar
• Langdon SP, Macleod KG. 2004. Cancer cell culture: Methods and protocols. In: Langdon SP, ed. Methods in molecular medicine. Totowa, NJ: Humana Press Inc., pp. 159–64.
   Google Scholar
• Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G. New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv, 2009;6(10):1017–32.
   PubMed Web of Science ®Google Scholar
• Lixia LV, Xiumei AN, Hongyan LI, Lanxiu MA. Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells. Oncol Lett, 2016;11:1161–6.
   PubMed Web of Science ®Google Scholar
• Ma P, Dong X, Swadley CL, Gupte A, Leggas M, Ledebur HC, Mumper RJ. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. J Biomed Nanotechnol, 2009;5:151–61.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E.M, Liversidge GG. Drug nanoparticles: Formulating poorly water-soluble compounds. Toxicol Pathol, 2008;36:43–8.
   PubMed Web of Science ®Google Scholar
• Miao J, Du YZ, Yuan H, Zhang XG, Hu FQ. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells. Colloids Surf B Biointerfaces, 2013;110:74–80.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev, 2001;53:283–318.
   PubMed Web of Science ®Google Scholar
• Petschauer JS, Madden AJ, Kirschbrown WP, Song G, Zamboni WC. The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents. Nanomedicine (Lond), 2015;10:447–63.
   PubMed Web of Science ®Google Scholar
• Scholes PD, Coombes AGA, Illum L, Davis SS, Watts JF, Ustariz C, Vert M, Davies MC. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J Contr Rel, 1999;59:261–78.
   PubMed Web of Science ®Google Scholar
• Shah M, Agrawal Y K, Garala K, Ramkishan A. Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride. Indian J Pharm Sci, 2012;74(5):434–42.
   PubMed Web of Science ®Google Scholar
• Singh S, Dobhal AK, Jain A, Pandit JK, Chakraborty S. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine. Chem Pharm Bull, 2010;58:650–5.
   PubMed Web of Science ®Google Scholar
• Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trials. Cancer, 2003;97:2869–79.
   PubMed Web of Science ®Google Scholar
• Szepeshazi K, Schally AV, Block NL, Halmos G, Nadji M, Szalontay L, Vidaurre I, Abi- Chaker A, Rick FG. Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108. Oncotarget, 2013;4:751–60.
   PubMed Web of Science ®Google Scholar
• Thukral DK, Dumoga S, Mishra AK. Solid lipid nanoparticles: Promising therapeutic nanocarriers for drug delivery. Curr Drug Deliv, 2014;11:771–91.
   PubMed Web of Science ®Google Scholar
• Trotta M, Gallarate M, Battaglia L, Chirio D. Cisplatin loaded SLN produced by coacervation technique. J Drug Deliv Sci Technol, 2010;20:343–7.
   Web of Science ®Google Scholar
• Trotta M, Gallarate M, Battaglia L, Peira E. Peptide loaded solid lipid nanoparticles prepared through coacervation technique. Int J Chem Eng, 2011;2011:132435.
   Google Scholar
• Wang Y, Li L, Jiang W, Yang Z, Zhang Z. Synthesis and preliminary antitumor activity evaluation of a DHA and doxorubicin conjugate. Bioorg Med Chem Lett, 2006;16(11):2974–7.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev, 2007;59:491–504.
   PubMed Web of Science ®Google Scholar